SG148840A1 - Indole derivatives useful for the treatment of cns disorders - Google Patents
Indole derivatives useful for the treatment of cns disordersInfo
- Publication number
- SG148840A1 SG148840A1 SG200501564-9A SG2005015649A SG148840A1 SG 148840 A1 SG148840 A1 SG 148840A1 SG 2005015649 A SG2005015649 A SG 2005015649A SG 148840 A1 SG148840 A1 SG 148840A1
- Authority
- SG
- Singapore
- Prior art keywords
- treatment
- cns disorders
- indole derivatives
- derivatives useful
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200000919 | 2000-06-14 | ||
US21244500P | 2000-06-16 | 2000-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG148840A1 true SG148840A1 (en) | 2009-01-29 |
Family
ID=26068835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200501564-9A SG148840A1 (en) | 2000-06-14 | 2001-06-13 | Indole derivatives useful for the treatment of cns disorders |
Country Status (20)
Country | Link |
---|---|
US (2) | US6890916B2 (pt) |
EP (1) | EP1294710B1 (pt) |
JP (1) | JP2004503550A (pt) |
KR (1) | KR20030007967A (pt) |
AR (1) | AR028685A1 (pt) |
AT (2) | ATE374197T1 (pt) |
AU (2) | AU7388101A (pt) |
BG (1) | BG107449A (pt) |
CA (1) | CA2411412C (pt) |
CZ (1) | CZ200335A3 (pt) |
DE (2) | DE60130691T2 (pt) |
DK (1) | DK1468996T3 (pt) |
ES (2) | ES2290587T3 (pt) |
HR (1) | HRP20021008A2 (pt) |
HU (1) | HUP0301735A2 (pt) |
NO (1) | NO323236B1 (pt) |
NZ (1) | NZ523076A (pt) |
PT (2) | PT1468996E (pt) |
SG (1) | SG148840A1 (pt) |
WO (1) | WO2001096328A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2165274B1 (es) * | 1999-06-04 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos. |
EP1468996B1 (en) * | 2000-06-14 | 2007-09-26 | H. Lundbeck A/S | Indole derivatives for the treatment of CNS disorders |
ES2172436B1 (es) | 2000-10-31 | 2004-01-16 | Almirall Prodesfarma Sa | Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos. |
WO2003102097A1 (en) * | 2002-05-31 | 2003-12-11 | H. Lundbeck A/S | The hydrochloride of (s)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1h-indole |
WO2004020437A1 (en) * | 2002-08-29 | 2004-03-11 | H. Lundbeck A/S | S-(+)-3-{1-[2-(2,3-dihydro-1h-indol-3-yl)ethyl]-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof |
GB0306604D0 (en) * | 2003-03-21 | 2003-04-30 | Curidium Ltd | Second medical use |
WO2004108671A1 (en) * | 2003-06-06 | 2004-12-16 | Suven Life Sciences Limited | Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them |
GB0708186D0 (en) * | 2007-04-27 | 2007-06-06 | Merck Sharp & Dohme | Therapeutic compounds |
SE531698C2 (sv) | 2007-07-12 | 2009-07-07 | Respiratorius Ab | Nya bronkdilaterande a,b-omättade amider |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998028293A1 (en) * | 1996-12-20 | 1998-07-02 | H.Lundbeck A/S | Indane or dihydroindole derivatives |
WO1999011619A1 (en) * | 1997-09-04 | 1999-03-11 | Merck Sharp & Dohme Limited | Phenylindole derivatives as 5-ht2a receptor ligands |
WO1999058525A1 (en) * | 1998-05-13 | 1999-11-18 | Eli Lilly And Company Limited | Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors |
WO2000031074A2 (en) * | 1998-11-19 | 2000-06-02 | Eli Lilly And Company Limited | Indole derivatives and their use as serotonin receptor ligands |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9202915D0 (en) * | 1992-02-12 | 1992-03-25 | Wellcome Found | Chemical compounds |
EP0897921A1 (en) * | 1997-08-22 | 1999-02-24 | Eli Lilly And Company Limited | Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands |
WO2000040581A1 (en) * | 1999-01-07 | 2000-07-13 | American Home Products Corporation | 3,4-dihydro-2h-benzo[1,4]oxazine derivatives |
EP1200072A2 (en) * | 1999-05-12 | 2002-05-02 | Solvay Pharmaceuticals B.V. | Method of treating psychotic disorders |
US6642228B1 (en) * | 1999-06-24 | 2003-11-04 | Toray Industries, Inc. | α1b-adrenergic receptor antagonists |
GB2362381A (en) * | 2000-05-18 | 2001-11-21 | Lilly Co Eli | Pharmaceutically active indolyl-piperidines |
-
2001
- 2001-06-06 AR ARP010102697A patent/AR028685A1/es not_active Application Discontinuation
- 2001-06-13 EP EP01940240A patent/EP1294710B1/en not_active Expired - Lifetime
- 2001-06-13 ES ES04012325T patent/ES2290587T3/es not_active Expired - Lifetime
- 2001-06-13 DK DK04012325T patent/DK1468996T3/da active
- 2001-06-13 PT PT04012325T patent/PT1468996E/pt unknown
- 2001-06-13 HU HU0301735A patent/HUP0301735A2/hu unknown
- 2001-06-13 PT PT01940240T patent/PT1294710E/pt unknown
- 2001-06-13 AT AT04012325T patent/ATE374197T1/de not_active IP Right Cessation
- 2001-06-13 CA CA002411412A patent/CA2411412C/en not_active Expired - Fee Related
- 2001-06-13 AU AU7388101A patent/AU7388101A/xx active Pending
- 2001-06-13 AU AU2001273881A patent/AU2001273881B8/en not_active Ceased
- 2001-06-13 SG SG200501564-9A patent/SG148840A1/en unknown
- 2001-06-13 DE DE60130691T patent/DE60130691T2/de not_active Expired - Fee Related
- 2001-06-13 NZ NZ523076A patent/NZ523076A/en unknown
- 2001-06-13 JP JP2002510470A patent/JP2004503550A/ja active Pending
- 2001-06-13 WO PCT/DK2001/000406 patent/WO2001096328A1/en active IP Right Grant
- 2001-06-13 KR KR1020027017034A patent/KR20030007967A/ko active IP Right Grant
- 2001-06-13 CZ CZ200335A patent/CZ200335A3/cs unknown
- 2001-06-13 ES ES01940240T patent/ES2243508T3/es not_active Expired - Lifetime
- 2001-06-13 AT AT01940240T patent/ATE297391T1/de not_active IP Right Cessation
- 2001-06-13 DE DE60111379T patent/DE60111379T2/de not_active Expired - Fee Related
-
2002
- 2002-12-09 US US10/315,927 patent/US6890916B2/en not_active Expired - Fee Related
- 2002-12-13 NO NO20026005A patent/NO323236B1/no unknown
- 2002-12-17 HR HR20021008A patent/HRP20021008A2/hr not_active Application Discontinuation
-
2003
- 2003-01-08 BG BG107449A patent/BG107449A/bg unknown
-
2005
- 2005-03-03 US US11/073,497 patent/US7276508B2/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998028293A1 (en) * | 1996-12-20 | 1998-07-02 | H.Lundbeck A/S | Indane or dihydroindole derivatives |
WO1999011619A1 (en) * | 1997-09-04 | 1999-03-11 | Merck Sharp & Dohme Limited | Phenylindole derivatives as 5-ht2a receptor ligands |
WO1999058525A1 (en) * | 1998-05-13 | 1999-11-18 | Eli Lilly And Company Limited | Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors |
WO2000031074A2 (en) * | 1998-11-19 | 2000-06-02 | Eli Lilly And Company Limited | Indole derivatives and their use as serotonin receptor ligands |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL143979A0 (en) | Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression | |
AU8187701A (en) | Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders | |
IL155589A0 (en) | Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders | |
AU2001271706A1 (en) | Use of substituted indole compounds for treating breast disorders | |
SG148840A1 (en) | Indole derivatives useful for the treatment of cns disorders | |
AU8322401A (en) | Indole compounds useful for the treatment of cancer | |
AU7961101A (en) | 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders | |
AU8173801A (en) | Indole derivatives useful for the treatment of cns disorders | |
PL347329A1 (en) | 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders | |
IL153254A0 (en) | Indole derivatives useful for the treatment of cns disorders | |
SI1468686T1 (sl) | S-metil-dihidro-ziprazidon za zdravljenje psihiatricnih motenj | |
NO20026028L (no) | Indolderivater nyttige for behandlingen av CNS-forstyrrelser | |
AU2002221566A1 (en) | Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders | |
IL153234A0 (en) | Indole derivatives useful for the treatment of cns disorders | |
IL153351A0 (en) | Indole derivatives useful for the treatment of cns disorders | |
SI1305307T1 (en) | Indole derivatives useful for the treatment of cns disorders | |
SI1294710T1 (en) | Indole derivatives useful for the treatment of cns disorders | |
AU6007900A (en) | Azetidine carboxamide derivatives for the treatment of cns disorders | |
AP2000001963A0 (en) | Paroxetine ascorbate. | |
SI1451177T1 (sl) | Substituirani 2-pirolidin-2-il-1H-indolni derivati za zdravljenje migrene | |
AP2000001958A0 (en) | Paroxetine 10-camphorsulfornate for treatment of CNS disorders. | |
SI1309586T1 (sl) | Derivati 4-,5-,6- in 7-indola uporabni za zdravljenje motenj cns |